Clarke Neumann - May 15, 2022 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIOR)

Role
Senior Vice President, General Counsel and Secretary
Signature
/s/ Will Pridgen, Attorney-in-Fact for Clarke Neumann
Stock symbol
BIOR
Transactions as of
May 15, 2022
Transactions value $
-$6,229
Form type
4
Date filed
5/17/2022, 05:27 PM
Previous filing
Apr 19, 2022
Next filing
Aug 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Tax liability -$6.23K -8.31K -2.62% $0.75 308K May 15, 2022 Direct F1
transaction BIOR Common Stock Award $0 +240K +77.83% $0.00 548K May 15, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOR Stock Option (Right to Buy) Award $0 +388K $0.00 388K May 15, 2022 Common Stock 388K $0.75 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 24,014 vested restricted stock units on May 15, 2022.
F2 Consists of 239,962 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer.
F3 This option represents the right to purchase 387,752 shares of the Issuer's common stock, 8,078 of which vested upon grant, with the remaining shares vesting in equal monthly installments through April 15, 2026, subject to the Reporting Person's continued service to the Issuer.

Remarks:

Senior Vice President, General Counsel and Secretary